Home/Filings/4/0001104659-24-072802
4//SEC Filing

Hooftman Leon 4

Accession 0001104659-24-072802

CIK 0001828185other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 4:07 PM ET

Size

6.0 KB

Accession

0001104659-24-072802

Insider Transaction Report

Form 4
Period: 2024-06-03
Hooftman Leon
Chief Medical Officer
Transactions
  • Award

    Share Option (Right to Buy)

    2024-06-03+195,166195,166 total
    Exercise: $2.00Exp: 2034-06-03Ordinary Shares (195,166 underlying)
Footnotes (2)
  • [F1]The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on June 3, 2025.
  • [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Issuer

Barinthus Biotherapeutics plc.

CIK 0001828185

Entity typeother

Related Parties

1
  • filerCIK 0002027157

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 4:07 PM ET
Size
6.0 KB